University of South Florida

Digital Commons @ University of South Florida
Neurology Faculty Publications

Neurology

2016

Unusual Late Onset of Parenchymal Neuro-Behçet Disease
Wai Wai Miller
University of South Florida

Demetrios Konstas
University of South Florida

Chetan Gandhy
University of South Florida, cgandhy@usf.edu

Derrick Robertson
University of South Florida, dsrobert@usf.edu

Follow this and additional works at: https://digitalcommons.usf.edu/neur_facpub
Part of the Neurology Commons

Scholar Commons Citation
Miller, Wai Wai; Konstas, Demetrios; Gandhy, Chetan; and Robertson, Derrick, "Unusual Late Onset of
Parenchymal Neuro-Behçet Disease" (2016). Neurology Faculty Publications. 66.
https://digitalcommons.usf.edu/neur_facpub/66

This Article is brought to you for free and open access by the Neurology at Digital Commons @ University of South
Florida. It has been accepted for inclusion in Neurology Faculty Publications by an authorized administrator of
Digital Commons @ University of South Florida. For more information, please contact scholarcommons@usf.edu.

Hindawi Publishing Corporation
Case Reports in Neurological Medicine
Volume 2016, Article ID 5720319, 3 pages
http://dx.doi.org/10.1155/2016/5720319

Case Report
Unusual Late Onset of Parenchymal Neuro-Behçet Disease
Wai Wai Miller,1,2 Demetrios Konstas,1,2 Chetan Gandhy,1,2 and Derrick Robertson1,2
1

Department of Neurology, University of South Florida, James A. Haley Veterans Hospital,
13000 Bruce B. Downs Boulevard VAH 127, Tampa, FL 33612, USA
2
Department of Neurology, University of South Florida, College of Medicine, Tampa, Fl 33612, USA
Correspondence should be addressed to Wai Wai Miller; wlwin@health.usf.edu
Received 7 March 2016; Revised 24 June 2016; Accepted 3 July 2016
Academic Editor: Samuel T. Gontkovsky
Copyright © 2016 Wai Wai Miller et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Neuro-Behçet disease (NBD) is a multisystem inflammatory disorder characterized by oral lesions, genital lesions, uveitis, and
neurological deficits. If left untreated, it may lead to worsening neurological function and can be fatal. Here we present a case of a 52year-old woman who was diagnosed with Behçet disease (BD) as a teenager and had a relatively mild disease course. Decades later
after her initial DB diagnosis, she presented to our hospital with a chief complaint of headache. She did not have focal neurological
deficits or any active mucosal lesions. Upon further investigation, the patient was found to have multiple inflammatory changes
on neuroimaging and abnormal cerebrospinal fluid (CSF), consistent with the diagnosis of NBD. She was treated with intravenous
corticosteroid therapy and her symptoms resolved. Although our patient presented with minimal symptoms decades after her
initial diagnosis, any neurological complaint warranted a thorough investigation for a proper diagnosis and treatment given the
multisystem involvement of BD.

1. Introduction
Behçet disease (BD) is a multisystem disorder that is characterized by oral-genital ulcers and uveitis. In Neuro-Behçet
disease (NBD), the central nervous system involvement can
be categorized as either parenchymal or nonparenchymal
[1]. The typical age of onset is between 20 and 40 years for
NBD, and men are more often affected than women [1]. In
prior studies, the mean duration between the onset of NBD
and time of developing BD ranged from 3 to 6 years [1].
In another study with a large cohort of NBD patients, the
median duration from BD diagnosis until NBD was 6 years
[2]. The diagnosis is made with clinical presentation, findings
on magnetic resonance imaging (MRI), and cerebrospinal
fluid (CSF) analysis. Here we present a patient who had an
unusual late onset of NBD after she was diagnosed with BD
decades earlier.

2. Case Presentation
Our patient is a 52-year-old Caucasian woman of German
descent with a remote history of BD diagnosed as a teenager
with recurrent oral lesions, genital lesions, and uveitis with

only mild exacerbations over the past 30 years, who presented
to us with a new onset headache. She reported that the
headache started about 4 weeks before and it was intermittent
at first but became constant 7 days prior to admission. She
described the headache as pressure-like pain at the occipital
regions bilaterally radiating to the vertex. Her headaches were
associated with intermittent bilateral ear pain. She denied any
focal weakness, nausea, vomiting, photophobia, or phonophobia. Aggravating factors for the headache included staring
at the computer screen at work. She tried over-the-counter
anti-inflammatories along with baclofen which helped initially. She denied any recent travel outside the US, had no
recent sick contacts, reported infrequent alcohol use, and
denied any toxic habits such as smoking and illicit drug use.
She had no previous history of similar headaches personally
or a family history of headaches. Physical examination,
including a detailed neurologic examination, was within
normal limits.
Of note, eight months prior to her presentation for
evaluation of her headache, she had an episode of acute
word-finding difficulties. She presented to our hospital and
was admitted for a workup of suspected ischemic stroke.
A brain MRI showed a focal T2 hyperintensity within the
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Figure 1: MRI brain T2 axial FLAIR sequence showed hyperintensities in the left thalamus and right mesial occipital lobe.
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levels, cytology, flow cytometry, IgG index, and oligoclonal
banding, were all normal. She was treated with high-dose
methylprednisolone leading to a complete resolution of her
headache.
In regard to her past medical history of BD, she initially
presented with recurrent oral ulcers and then a short time
later developed recurrent genital ulcers and uveitis at age
of 17. She was evaluated by multiple medical specialists
and underwent an extensive workup. Subsequently, she was
diagnosed with BD. She was started on oral prednisone,
which she took for approximately 3 years and eventually selfdiscontinued because of prednisone side effects (weight gain,
mood fluctuations). She had not had exacerbation with oral
or eye lesions in over 30 years but did have infrequent bouts of
genital ulcers. These exacerbations typically occurred in the
setting of a stressor, such as an upper respiratory infection.
Her last genital outbreak was one month prior to admission
for headache. She had been tested before for HLA-B51, whose
carriers have an increased risk of developing BD, but was
negative and has no known family history of BD.

3. Discussion

Figure 2: MRI cervical spine T2 sagittal sequence showed a
hyperintensity extending from C1 to C2.

posterior left temporal lobe assumed to be due to an acute
ischemic stroke. She was admitted and further workup was
unrevealing of the etiology of her suspected ischemic stroke.
As an outpatient, a repeat brain MRI one month after
hospitalization showed resolution of this left temporal lesion.
Clinically, the patient reported complete resolution of her
word-finding difficulties.
On the admission to evaluate her headache, a repeat brain
MRI showed T2 hyperintensities in the left thalamus, right
mesial occipital lobe, and left brachium pontis (Figure 1). The
MRI of the cervical spine showed an abnormal T2 hyperintensity within the cervical spinal cord at the level of C1-2
(Figure 2). CSF analysis revealed elevated nucleated cells and
protein at 114/𝜇L and 165 mg/dL, respectively. Additional CSF
analyses, including glucose, angiotensin-converting enzyme

NBD disease is classified as either parenchymal or nonparenchymal. Parenchymal disease accounts for 75% of cases,
and headache is the most common neurological symptom,
occurring in about 70% of patients [1]. NBD can be acute
or chronic. Acute NBD is often seen as meningoencephalitis
and typically responds well to corticosteroid therapy. Acute
NBD tends to be self-limiting and carries a better prognosis
as opposed to chronic progressive NBD, which is intractable
and often times leads to severe disability and deterioration
[3]. Some patients may not present with any overt neurological deficits but rather with vague nonfocal neurological
symptoms, such as headache or dizziness [4]. Our patient
presented to the hospital with new onset headache being the
only symptom and no other neurological deficits were noted.
She received a high-dose intravenous corticosteroid treatment and her symptoms quickly resolved. This subclinical
acute NBD may be mistaken for chronic progressive NBD;
however they have different prognoses. Although the etiology
is still unclear, this subclinical NBD is potentially thought to
be a different form of NBD rather than the earlier stages of
chronic progressive NBD [4]. Further studies are needed to
better define this.
Just like clinical symptoms, MRI findings are also nonspecific in NBD. Typically, there is a single lesion during the
acute phase, but the lesions can be diffuse and widespread
during the chronic phase [1]. The shape of the lesions seen on
T2-weighted images varies from circular, linear, or crescentshaped to irregular [5]. Bilateral lesions are uncommon [1].
Lesions are typically located in the brain stem, thalamus,
or basal ganglia and decrease in size with steroid or other
immunosuppressive therapies [5]. The presence of brainstem
atrophy can be seen in chronic progressive NBD [6].
CSF analysis in NBD typically reveals increased cell
counts and protein. CSF neutrophilia can be seen in the
early stages with lymphocytosis being seen in the later stage
[1]. Oligoclonal bands are usually absent. Our patient’s CSF
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analysis was consistent with NBD as it showed elevated
cell counts with neutrophilia, elevated protein, and absent
oligoclonal bands.
Estimation of prognosis for NBD is based on many
different factors. In patients with chronic progressive NBD,
the presence of brainstem atrophy and abnormal CSF
findings have a poorer prognosis [1]. Also, patients with
spinal cord and brainstem lesions are more likely to have
incomplete recovery and thus have higher levels of disability [1]. Our patient’s presentation is consistent with the
most common type, parenchymal NBD. She did not have
brainstem atrophy seen on neuroimaging but had lesions
in cervical spinal cord and abnormal CSF findings, thus
making an accurate determination of her prognosis difficult.
Additionally, one-third of the patients with parenchymal
NBD may relapse or become progressive even after appropriate treatment [7]. Therefore, our patient received prolonged corticosteroid taper upon discharge from the hospital
and potentially will require long-term immunosuppressive
agents.
Here we presented a patient with a myriad of uncommon
NBD findings. She was a female over the age of 50 years
who has had a relatively benign disease course of her BD
for several decades. As mentioned above, NBD typically is
diagnosed in the 3rd or 4th decade of life, presentation
is 3 to 6 years after the onset of BD and it occurs more
often in men. She did not present with systemic mucosal
lesions or uveitis at the time of admission, contrary to the
typical presentation of parenchymal NBD which often has
concurrent systemic features of BD [1]. Some of the locations
of the lesions on her MRI were uncommon in that they
occurred bilaterally and affected the cervical spinal cord.
Further confounding her clinical picture was her initial
admission, months prior to the diagnosis of NBD, with
acute word-finding difficulties. It is possible that this was
the beginning of NBD in our patient; however the lack of a
full diagnostic workup, including CSF analysis, makes that
determination impossible retrospectively.
In conclusion, the diagnosis of NBD should be made
cautiously in patients above the age of 50 years. Specifically
excluding other more common neurological disorders, particularly stroke, is critical in obtaining a proper diagnosis.
NBD should be considered in the differential diagnosis of
any BD patient with new headache or other neurological
complaints regardless of the prior status of their BD including
disease duration and level of disability.
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